| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 520 | 504 | 502 | 526 | 523 | 528 | 552 | 568 | 580 | 619 | 756 | 795 | |
Growth YoY Revenue Growth YoY% | -0.6 | -14.2 | -10.8 | -3.6 | 0.6 | 4.7 | 9.8 | 8.0 | 10.9 | 17.4 | 37.1 | 40.1 |
| 476 | 454 | 451 | 484 | 476 | 465 | 490 | 510 | 523 | 527 | 653 | 686 | |
| 44 | 50 | 51 | 42 | 47 | 63 | 62 | 57 | 57 | 92 | 103 | 109 | |
OPM OPM% | 8.5 | 9.8 | 10.2 | 7.9 | 9.0 | 11.9 | 11.3 | 10.1 | 9.9 | 14.9 | 13.7 | 13.8 |
| 8 | 8 | 7 | 6 | 4 | 5 | 7 | 7 | -6 | 2 | 8 | 6 | |
Interest Expense Interest ExpenseCr | 4 | 3 | 2 | 4 | 4 | 4 | 4 | 3 | 4 | 3 | 4 | 5 |
Depreciation DepreciationCr | 16 | 16 | 17 | 18 | 19 | 19 | 20 | 20 | 20 | 20 | 21 | 22 |
PBT PBTCr | 32 | 37 | 40 | 26 | 28 | 45 | 46 | 40 | 28 | 71 | 87 | 87 |
| 9 | 10 | 10 | 7 | 7 | 13 | 12 | 11 | 7 | 18 | 22 | 22 | |
| 23 | 28 | 30 | 19 | 21 | 31 | 34 | 30 | 21 | 53 | 64 | 65 | |
Growth YoY PAT Growth YoY% | -2.9 | -57.4 | -34.6 | -49.4 | -11.1 | 13.8 | 13.2 | 56.5 | 0.2 | 69.2 | 89.8 | 117.1 |
NPM NPM% | 4.4 | 5.5 | 6.0 | 3.6 | 3.9 | 6.0 | 6.2 | 5.3 | 3.5 | 8.6 | 8.5 | 8.2 |
| 0.8 | 0.9 | 1.0 | 0.7 | 0.7 | 1.1 | 1.2 | 1.0 | 0.7 | 1.8 | 2.2 | 2.2 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 520 | 504 | 502 | 526 | 523 | 528 | 552 | 568 | 580 | 619 | 756 | 795 | |
Growth YoY Revenue Growth YoY% | -0.6 | -14.2 | -10.8 | -3.6 | 0.6 | 4.7 | 9.8 | 8.0 | 10.9 | 17.4 | 37.1 | 40.1 |
| 476 | 454 | 451 | 484 | 476 | 465 | 490 | 510 | 523 | 527 | 653 | 686 | |
| 44 | 50 | 51 | 42 | 47 | 63 | 62 | 57 | 57 | 92 | 103 | 109 | |
OPM OPM% | 8.5 | 9.8 | 10.2 | 7.9 | 9.0 | 11.9 | 11.3 | 10.1 | 9.9 | 14.9 | 13.7 | 13.8 |
| 8 | 8 | 7 | 6 | 4 | 5 | 7 | 7 | -6 | 2 | 8 | 6 | |
Interest Expense Interest ExpenseCr | 4 | 3 | 2 | 4 | 4 | 4 | 4 | 3 | 4 | 3 | 4 | 5 |
Depreciation DepreciationCr | 16 | 16 | 17 | 18 | 19 | 19 | 20 | 20 | 20 | 20 | 21 | 22 |
PBT PBTCr | 32 | 37 | 40 | 26 | 28 | 45 | 46 | 40 | 28 | 71 | 87 | 87 |
| 9 | 10 | 10 | 7 | 7 | 13 | 12 | 11 | 7 | 18 | 22 | 22 | |
| 23 | 28 | 30 | 19 | 21 | 31 | 34 | 30 | 21 | 53 | 64 | 65 | |
Growth YoY PAT Growth YoY% | -2.9 | -57.4 | -34.6 | -49.4 | -11.1 | 13.8 | 13.2 | 56.5 | 0.2 | 69.2 | 89.8 | 117.1 |
NPM NPM% | 4.4 | 5.5 | 6.0 | 3.6 | 3.9 | 6.0 | 6.2 | 5.3 | 3.5 | 8.6 | 8.5 | 8.2 |
| 0.8 | 0.9 | 1.0 | 0.7 | 0.7 | 1.1 | 1.2 | 1.0 | 0.7 | 1.8 | 2.2 | 2.2 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 2,184 | 2,217 | 2,133 | 2,079 | 2,319 | 2,751 |
Growth Revenue Growth% | 1.5 | -3.8 | -2.5 | 11.5 | 26.8 | |
| 1,926 | 1,991 | 1,902 | 1,877 | 2,050 | 2,388 | |
| 258 | 226 | 231 | 202 | 269 | 363 | |
OPM OPM% | 11.8 | 10.2 | 10.8 | 9.7 | 11.6 | 13.2 |
| 18 | 26 | 30 | 22 | 10 | 10 | |
Interest Expense Interest ExpenseCr | 8 | 16 | 16 | 15 | 15 | 16 |
Depreciation DepreciationCr | 43 | 46 | 63 | 72 | 80 | 84 |
PBT PBTCr | 225 | 189 | 182 | 138 | 184 | 272 |
| 57 | 50 | 47 | 37 | 47 | 69 | |
PAT PATCr | 168 | 139 | 134 | 101 | 138 | 203 |
Growth PAT Growth% | -17.0 | -3.4 | -24.8 | 36.2 | 75.4 | |
NPM NPM% | 7.7 | 6.3 | 6.3 | 4.9 | 5.9 | 7.4 |
| 5.7 | 4.7 | 4.6 | 3.4 | 4.7 | 6.9 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 2,184 | 2,217 | 2,133 | 2,079 | 2,319 | 2,751 |
Growth Revenue Growth% | 1.5 | -3.8 | -2.5 | 11.5 | 26.8 | |
| 1,926 | 1,991 | 1,902 | 1,877 | 2,050 | 2,388 | |
| 258 | 226 | 231 | 202 | 269 | 363 | |
OPM OPM% | 11.8 | 10.2 | 10.8 | 9.7 | 11.6 | 13.2 |
| 18 | 26 | 30 | 22 | 10 | 10 | |
Interest Expense Interest ExpenseCr | 8 | 16 | 16 | 15 | 15 | 16 |
Depreciation DepreciationCr | 43 | 46 | 63 | 72 | 80 | 84 |
PBT PBTCr | 225 | 189 | 182 | 138 | 184 | 272 |
| 57 | 50 | 47 | 37 | 47 | 69 | |
PAT PATCr | 168 | 139 | 134 | 101 | 138 | 203 |
Growth PAT Growth% | -17.0 | -3.4 | -24.8 | 36.2 | 75.4 | |
NPM NPM% | 7.7 | 6.3 | 6.3 | 4.9 | 5.9 | 7.4 |
| 5.7 | 4.7 | 4.6 | 3.4 | 4.7 | 6.9 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 59 | 59 | 59 | 59 | 59 | 59 |
Reserves ReservesCr | 1,334 | 1,449 | 1,553 | 1,629 | 1,740 | 1,867 |
| 513 | 456 | 560 | 610 | 690 | 801 | |
| 57 | 58 | 73 | 85 | 98 | 104 | |
| 1,962 | 2,022 | 2,244 | 2,382 | 2,587 | 2,831 | |
| 1,081 | 920 | 1,120 | 1,151 | 1,228 | 1,366 | |
| 881 | 1,102 | 1,125 | 1,231 | 1,359 | 1,464 | |
| 1,962 | 2,022 | 2,244 | 2,382 | 2,587 | 2,831 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 59 | 59 | 59 | 59 | 59 | 59 |
Reserves ReservesCr | 1,334 | 1,449 | 1,553 | 1,629 | 1,740 | 1,867 |
| 513 | 456 | 560 | 610 | 690 | 801 | |
| 57 | 58 | 73 | 85 | 98 | 104 | |
| 1,962 | 2,022 | 2,244 | 2,382 | 2,587 | 2,831 | |
| 1,081 | 920 | 1,120 | 1,151 | 1,228 | 1,366 | |
| 881 | 1,102 | 1,125 | 1,231 | 1,359 | 1,464 | |
| 1,962 | 2,022 | 2,244 | 2,382 | 2,587 | 2,831 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 93 | 122 | 290 | 179 | 214 | |
| -121 | -120 | -191 | -154 | -198 | |
| -2 | -4 | -93 | 46 | -29 | |
Net Cash Flow Net Cash FlowCr | -29 | -2 | 6 | 70 | -13 |
Free Cash Flow Free Cash FlowCr | -58 | -87 | 17 | -34 | 43 |
CFO To PAT CFO To PAT% | 55.5 | 87.9 | 215.6 | 176.7 | 155.7 |
CFO To EBITDA CFO To EBITDA% | 36.0 | 54.2 | 125.7 | 88.3 | 79.7 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| 93 | 122 | 290 | 179 | 214 | |
| -121 | -120 | -191 | -154 | -198 | |
| -2 | -4 | -93 | 46 | -29 | |
Net Cash Flow Net Cash FlowCr | -29 | -2 | 6 | 70 | -13 |
Free Cash Flow Free Cash FlowCr | -58 | -87 | 17 | -34 | 43 |
CFO To PAT CFO To PAT% | 55.5 | 87.9 | 215.6 | 176.7 | 155.7 |
CFO To EBITDA CFO To EBITDA% | 36.0 | 54.2 | 125.7 | 88.3 | 79.7 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 2,077 | 1,661 | 2,122 | 1,796 | 2,135 | 5,404 |
Price To Earnings Price To Earnings | 12.4 | 11.9 | 15.8 | 17.8 | 15.5 | 26.6 |
Price To Sales Price To Sales | 0.9 | 0.8 | 1.0 | 0.9 | 0.9 | 2.0 |
Price To Book Price To Book | 1.5 | 1.1 | 1.3 | 1.1 | 1.2 | 2.8 |
EV To EBITDA EV To EBITDA | 7.7 | 7.6 | 8.7 | 8.4 | 7.7 | 15.1 |
GPM GPM% | 22.8 | 22.3 | 25.3 | 25.3 | 26.7 | 26.7 |
OPM OPM% | 11.8 | 10.2 | 10.8 | 9.7 | 11.6 | 13.2 |
NPM NPM% | 7.7 | 6.3 | 6.3 | 4.9 | 5.9 | 7.4 |
ROCE ROCE% | 16.2 | 12.9 | 12.0 | 8.5 | 10.3 | 13.6 |
ROE ROE% | 12.0 | 9.2 | 8.3 | 6.0 | 7.7 | 10.6 |
ROA ROA% | 8.5 | 6.9 | 6.0 | 4.2 | 5.3 | 7.2 |
| Financial Year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 2,077 | 1,661 | 2,122 | 1,796 | 2,135 | 5,404 |
Price To Earnings Price To Earnings | 12.4 | 11.9 | 15.8 | 17.8 | 15.5 | 26.6 |
Price To Sales Price To Sales | 0.9 | 0.8 | 1.0 | 0.9 | 0.9 | 2.0 |
Price To Book Price To Book | 1.5 | 1.1 | 1.3 | 1.1 | 1.2 | 2.8 |
EV To EBITDA EV To EBITDA | 7.7 | 7.6 | 8.7 | 8.4 | 7.7 | 15.1 |
GPM GPM% | 22.8 | 22.3 | 25.3 | 25.3 | 26.7 | 26.7 |
OPM OPM% | 11.8 | 10.2 | 10.8 | 9.7 | 11.6 | 13.2 |
NPM NPM% | 7.7 | 6.3 | 6.3 | 4.9 | 5.9 | 7.4 |
ROCE ROCE% | 16.2 | 12.9 | 12.0 | 8.5 | 10.3 | 13.6 |
ROE ROE% | 12.0 | 9.2 | 8.3 | 6.0 | 7.7 | 10.6 |
ROA ROA% | 8.5 | 6.9 | 6.0 | 4.2 | 5.3 | 7.2 |
| Market CapitalizationMkt CapCr | 10,272 | 8,984 | 5,751 | 5,404 | 4,991 | 4,940 | 4,590 |
| Close PriceClose₹ | 1,598.60 | 990.70 | 960.40 | 184.12 | 620.15 | 90.15 | 352.70 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 75.80 | 34.99 | 134.70 | 26.61 | 28.18 | 26.28 | 213.76 |
| Price To SalesPS | 11.82 | 4.16 | 4.71 | 1.96 | 5.68 | 2.16 | 27.68 |
| RevenueRevenueCr | 869 | 2,161 | 1,221 | 2,751 | 879 | 2,286 | 166 |
| Revenue Growth TTMRev Gr TTM% | 13.4% | 20.1% | 26.8% | 23.0% | 30.2% | ||
| PAT Growth TTMPAT Gr TTM% | 7.1% | 16.5% | 75.4% | -2.8% | 89.5% |
| Market CapitalizationMkt CapCr | 10,272 | 8,984 | 5,751 | 5,404 | 4,991 | 4,940 | 4,590 |
| Close PriceClose₹ | 1,598.60 | 990.70 | 960.40 | 184.12 | 620.15 | 90.15 | 352.70 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 75.80 | 34.99 | 134.70 | 26.61 | 28.18 | 26.28 | 213.76 |
| Price To SalesPS | 11.82 | 4.16 | 4.71 | 1.96 | 5.68 | 2.16 | 27.68 |
| RevenueRevenueCr | 869 | 2,161 | 1,221 | 2,751 | 879 | 2,286 | 166 |
| Revenue Growth TTMRev Gr TTM% | 13.4% | 20.1% | 26.8% | 23.0% | 30.2% | ||
| PAT Growth TTMPAT Gr TTM% | 7.1% | 16.5% | 75.4% | -2.8% | 89.5% |